Alison Lawton
2018 - Kaleido Biosciences
In 2018, Alison Lawton earned a total compensation of $6.6M as President and Chief Executive Officer principal executive officer at Kaleido Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $5,947,117 |
| Salary | $437,500 |
| Other | $9,512 |
| Total | $6,644,129 |
Lawton received $5.9M in option awards, accounting for 90% of the total pay in 2018.
Lawton also received $250K in non-equity incentive plan, $437.5K in salary and $9.5K in other compensation.
Rankings
In 2018, Alison Lawton's compensation ranked 1,353rd out of 14,244 executives tracked by ExecPay. In other words, Lawton earned more than 90.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,353 out of 14,244 | 91st |
Division Manufacturing | 470 out of 5,765 | 92nd |
Major group Chemicals And Allied Products | 147 out of 2,128 | 93rd |
Industry group Drugs | 114 out of 1,817 | 94th |
Industry Biological Products, Except Diagnostic Substances | 28 out of 339 | 92nd |
Source: SEC filing on May 8, 2020.
Lawton's colleagues
We found two more compensation records of executives who worked with Alison Lawton at Kaleido Biosciences in 2018.